Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease

NCT03774784 is registered in ClinicalTrials.gov with Alnylam Pharmaceuticals as lead sponsor.

NCT NCT03774784
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03774784 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of the Natural History of Leukocyte Chemotactic Factor 2 Amyloidosis (ALECT2) Disease
Lead sponsor
Alnylam Pharmaceuticals
Phase
Observational
Overall status
Terminated
Start date
January 29, 2019
Completion date
May 18, 2020
Enrollment
26 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

amyloidosis, leukocyte chemotactic factor 2 amyloidosis